Matija Gredicak

Dr. Matija Gredicak

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2015 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JSJosipa Suć
Josipa Suć
IDIrena Dokli
Irena Dokli
MGMatija Gredicak
Matija Gredicak
The first organocatalytic asymmetric addition of thiols to N-acyl ketimines, which are generated in situ from 3-hydroxy isoindolinones, is described. The reaction proceeds smoothly with a broad range of ketimines and thiols using a chiral Brønsted acid catalyst to afford N(acyl),S-acetals comprising a tetrasubstituted stereocenter in high yields and enantioselectivities (up to 98.5 : 1.5 e.r.). The usefulness of the developed protocol is demonstrated in the synthesis of a known HIV-1 reverse transcriptase inhibitor.

2 August 2017 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
DGDanijel Glavač
Danijel Glavač
CZChao Zheng
Chao Zheng
IDIrena Dokli
Irena Dokli
SYShu-Li You
Shu-Li You
MGMatija Gredicak
Matija Gredicak

1 June 2007 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
MGMatija Gredicak
Matija Gredicak
IJIvanka Jerić
Ivanka Jerić
Enediyne compounds - new promises in anticancer therapy: Scientists of all kinds have long been intrigued by the nature, action and potential of natural toxins that possess exceptional antibacterial and anticancer activities. These compounds, named enediynes, are among the most effective chemotherapeutic agents known. Often compared with intelligent weapons, due to the unique structure and sophisticated mechanism by which they destroy double-helical DNA, enediyne antibiotics are nowadays the most promising leaders in the anticancer therapy. Apart from their diversity, enediyne compounds share some structural and functional similarities. One fragment of a structure is responsible for the recognition and transport, another part acts as molecular trigger while the third, reactive enediyne unit, undergoes Bergman cycloaromatization and causes DNA breakage. Members of the enediyne family are already in clinical use to treat various cancers, but more general use is limited by their complex structure, which makes them formidable targets for synthetic chemists. There are three main approaches in the design of new enediyne-related compounds: improvement of enediyne "warheads", increasing the selectivity and control of chemical or photo-induced activation. This paper gives an overview of naturally occurring enediynes, their mode of action and efforts undertaken to design artificial enediyne-related DNA cleaving agents.

13 March 2015 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
IDIrena Dokli
Irena Dokli
MGMatija Gredicak
Matija Gredicak

6 May 2021 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
NTNikola Topolovčan
Nikola Topolovčan
MGMatija Gredicak
Matija Gredicak
This review highlights recent advancement in the synthesis of 3-hydroxyisoindolinones and their applications in stereoselective transformations.

1 January 2012 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
MUMarko Ukrainczyk
Marko Ukrainczyk
MGMatija Gredicak
Matija Gredicak
IJIvanka Jerić
Ivanka Jerić
DKDamir Kralj
Damir Kralj